Senate committee advances Dr. Nicole Saphier’s nomination for surgeon general

Dr. Nicole Saphier, President Donald Trump’s third nominee for surgeon general, moved a step closer to confirmation after a Senate committee voted to advance her nomination on Wednesday.

Saphier, a radiologist and former Fox News Channel contributor, was advanced out of the Senate Committee on Health, Education, Labor and Pensions on a 12 to 11 vote to serve as surgeon general after she was grilled at her confirmation hearing earlier this month about her stance on childhood vaccines.

She expressed support for vaccines and told lawmakers she didn’t believe they cause autism. The Trump administration has sought to revisit claims about a link between vaccines and autism, although widespread scientific consensus and decades of studies have firmly concluded there is none.

Timothy Westlake, who was nominated to serve as assistant secretary for mental health and substance use at the Department of Health and Human Services was also advanced out of committee on the same en bloc vote.

It was not immediately clear when the officials would face a full Senate vote for their confirmation but they are expected to be approved.

During her confirmation hearing, Republican Sen. Bill Cassidy pressed Saphier to declare whether she believed there was a link between vaccines and autism. Saphier responded that she does “not believe childhood vaccines cause autism,” adding that “the MMR vaccine is our greatest tool for combating measles,” in response to a question by Cassidy over whether parents should give children that shot.

MMR stands for measles, mumps and rubella, and the president recently called for the shots to be spaced out, against the guidance of medical groups.

The surgeon general position carries limited policymaking power but serves as a loud megaphone as the nation’s top communicator to Americans on public health issues.

For Subscribers

FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane

FOR SUBSCRIBERSOpenAI CEO Sam Altman to skip congressional hearing on rogue AI agents

FOR SUBSCRIBERSKey DOJ lawyers departed Trump ‘grand conspiracy’ probe amid pressure to produce, source says

FOR SUBSCRIBERSTrump’s new AI chatbot often links to a site launched under Clinton 26 years ago

FOR SUBSCRIBERSAt MAHA summit, industry CEOs the movement once vilified take the stage

FOR SUBSCRIBERSThis Paralympian has two goals: Win medals and give away $500,000 to her teammates

FOR SUBSCRIBERSCornell rape allegation spotlights stringent New York state laws that have long drawn criticism

FOR SUBSCRIBERSThe debate over AI’s future rages on both coasts

FOR SUBSCRIBERSDecades-old march dispute reignites in Northern Ireland, threatening political crisis

FOR SUBSCRIBERSMore oil is getting out of the Middle East. Why is it still so expensive?

FOR SUBSCRIBERSThe complicated bargain between ‘looksmaxxing’ influencer Clavicular and the women in his orbit

FOR SUBSCRIBERSSenators unveil bipartisan bill to deliver essential newborn supply kits to new moms

FOR SUBSCRIBERSAI agents promise to run your errands. Websites are fighting back.

FOR SUBSCRIBERSDemocrats face a staggering spending disadvantage in Georgia’s tight race for governor

FOR SUBSCRIBERSObama boosts Senate Democrats with October fundraiser

For Subscribers

FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane

FOR SUBSCRIBERSOpenAI CEO Sam Altman to skip congressional hearing on rogue AI agents

FOR SUBSCRIBERSKey DOJ lawyers departed Trump ‘grand conspiracy’ probe amid pressure to produce, source says

FOR SUBSCRIBERSTrump’s new AI chatbot often links to a site launched under Clinton 26 years ago

FOR SUBSCRIBERSAt MAHA summit, industry CEOs the movement once vilified take the stage

FOR SUBSCRIBERSThis Paralympian has two goals: Win medals and give away $500,000 to her teammates

FOR SUBSCRIBERSCornell rape allegation spotlights stringent New York state laws that have long drawn criticism

FOR SUBSCRIBERSThe debate over AI’s future rages on both coasts

FOR SUBSCRIBERSDecades-old march dispute reignites in Northern Ireland, threatening political crisis

FOR SUBSCRIBERSMore oil is getting out of the Middle East. Why is it still so expensive?

FOR SUBSCRIBERSThe complicated bargain between ‘looksmaxxing’ influencer Clavicular and the women in his orbit

FOR SUBSCRIBERSSenators unveil bipartisan bill to deliver essential newborn supply kits to new moms

FOR SUBSCRIBERSAI agents promise to run your errands. Websites are fighting back.

FOR SUBSCRIBERSDemocrats face a staggering spending disadvantage in Georgia’s tight race for governor

FOR SUBSCRIBERSObama boosts Senate Democrats with October fundraiser

Cassidy, who led the inquiry into Saphier’s views on vaccines, ultimately voted in support of her nomination.

Sen. Bernie Sanders, the ranking member of the Senate HELP committee, said ahead of Saphier’s vote that he would vote down her nomination because in part Saphier “has questioned the need for the hepatitis B vaccine at birth, when the data science has been clear.”

“We need a surgeon general who will tell the truth about vaccines, not someone who misleads the public,” Sanders said. At her confirmation hearing, Saphier said the universal birth dose of hepatitis B was safe and effective.

Chris Klomp, who was nominated to serve as deputy secretary of the Department of Health and Human Services, was advanced out of the Senate Finance Committee last week on a 15 to 12 vote. He was questioned during the same hearing as Saphier about his duties associated with the role as the current chief counselor of the Department of Health and Human Services under the leadership of Health Secretary Robert F. Kennedy Jr. as well as about his vaccine stance.

In protesting Klomp’s nomination at the Senate Finance Committee, Sen. Ron Wyden said Klomp “tried to create the impression that he will be the adult in the room on vaccines. Yet, as we sit here today, the vaccine chaos that we’ve come to expect from Robert Kennedy’s HHS continues.”